Related Experiment Video
Updated: Jul 9, 2026

Intravital Imaging of Intraepithelial Lymphocytes in Murine Small Intestine
Published on: June 24, 2019
GPR55 negatively regulates CD8+ intraepithelial lymphocyte migration dynamics in oral lichen planus
Dongyang Zhou1, Gang Zhou2,3
1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of Stomatology, Wuhan University, Wuhan, China.
None:
Oral lichen planus (OLP) is a prevalent T-cell-mediated inflammatory disease of the human oral mucosa. Intraepithelial lymphocytes (IELs) engage in close cellular interactions with epithelial keratinocytes; however, the molecular mechanisms governing their migration and dynamic crosstalk with the epithelium remain incompletely defined. Here, we demonstrate that TCRαβ+CD8αα+ and TCRγδ+CD8αα+ IELs represent two key CD8αα+ subsets within the total IEL population in OLP lesions. Live-cell imaging revealed that CD8αα⁻ IELs exhibited slower migratory kinetics compared with their CD8αα+ counterparts, confirming that surface CD8αα expression facilitates epithelial migration of CD8+ IELs. Within inflamed OLP mucosa, CD8αα+ IELs produce markedly elevated levels of the pro-inflammatory cytokines IL-17 A and IFN-γ. Neutralization of these two cytokines with specific antibodies reduced the migratory capacity of both CD8αα+ and CD8αα⁻ IELs, indicating that the inflammatory microenvironment promoted CD8+ IEL recruitment into lesional epithelium. GPR55 was highly expressed in CD8αα+ IELs. Pharmacological blockade of GPR55 suppressed proliferation and significantly induced apoptosis in both IEL subsets. Furthermore, GPR55 antagonism robustly enhanced IEL migration and strengthened cell-to-cell contacts between IELs and oral keratinocytes (KCs). These findings identify GPR55 as a negative regulator that restricts transmigration of CD8+ IELs into the oral epithelium. Targeted GPR55 inhibition may represent a promising strategy to modulate aberrant IEL activity and preserve mucosal epithelial barrier integrity in OLP.